Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
In the SURMOUNT-1 trial, participants without diabetes achieved an average body weight reduction of up to about 22.5% after 72 weeks at the highest dose, one of the largest reductions reported for a medication in obesity research
So you don't get as sick
Injectable protocols follow different guidelines than topical applications
Theres typically strict criteria for who can be approved for these medications for weight loss purposes
These individuals have typically found their minimum effective maintenance dose and view the medication as routine health management
US$ 29.35
US$ 25.30
US$ 22.43
)
US$ 28.12
